Cuban Delegation Meet with BioTech Innovation Leadership @UofA

Senior executives of Cuba’s pharmaceutical industry traveled to the University of Arizona for meetings with Dr. Marvin J. Slepian, the founder and director of the Arizona Center for Accelerated Biomedical Innovation(ACABI), David G. Armstrong, Professor of Surgery and Director of the Southern Arizona Limb Salvage Alliance (SALSA) and the officers and founders of Mercurio Biotec. “We are enormously excited about the ability explore the possibility to help countless patients” noted Dr. Armstrong, “but also the possibility to create a novel pan-American Alliance.”

Dr. Mayda Mauri Perez, commercial and business director BioCubaFarma, Dr. Luis Herrera, Scientific and Commercial Director BioCubaFarma, Ruben Ramos-Arrieta, Cuban Embassy Trade Minister and Eulogio Pimentel, General Director for Cuba’s Center for Genetic Engineering and Biotechnology met with Drs Slepian and Armstrong and the four founders of Mercurio Biotec, Carlton Anderson, CEO, Milton Sanchez-Parodi, President and Chief Medical Officer, Samuel Riega, Executive Vice-President and Luis M. Alcalde, Vice-President and General Counsel to discuss business and medical collaborations. Mercurio Biotec has been granted a license by the U.S. government to enter into agreements with CIGB for the purpose of exporting Cuba’s famous diabetic foot ulcer treatment to the United States. Working in collaboration with the University of Arizona, ACABI will help steward this promising new therapy through the clinical trial, regulatory and reimbursement hurdles/steps. University of Arizona’s SALSA, a world renowned center in the management of the diabetic foot, will oversee the clinical trial and study coordination.  Dr. Slepian concluded that “This great team has the potential to bring this and other new promising therapeutic technologies on shore to the US for clinical benefit.”

IMG_0083 (1)
Members of the Cuban-American Biotech Conclave (from L): Marvin J. Slepian, Milton Sanchez-Parodi, Luis Herrera, Carlton Anderson, Mayda Mauri Perez, Ruben Ramos, Eulogio Pimentel, David G. Armstrong, Luis M. Alcalde and Samuel Riega

David G. Armstrong

Dedicated to amputation prevention, wound healing, diabetic foot, biotechnology and the intersection between medical devices and consumer electronics.

Submit a comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s